Join us at Clinical Nutrition Week

Join us January 16-19, 2016 in Austin, TX at Clinical Nutrition Week hosted by ASPEN. Visit us at Booth #120 to see the TubeClear System in action. This is a great opportunity to try out the system and ask questions to our experts.

Comments Off on Join us at Clinical Nutrition Week

CORPAK Selected as Worldwide Distributor

CORPAK MedSystems, Inc. is pleased to announce its selection as the worldwide exclusive distributor of TubeClear for the acute care market. “CORPAK is excited to add TubeClear to our portfolio of best-in-class enteral feeding products,” according to Frank J. McCaney, CEO of CORPAK, who added, “TubeClear is an innovative product that will assist clinicians in providing improved patient care as well as decreasing costs and uncomfortable procedures.”

Comments Off on CORPAK Selected as Worldwide Distributor

Partnership with PSU Nursing School

Actuated Medical’s partnership with Penn State’s College of nursing helped speed TubeClear to market and ensure clinician adoption. Janice Penrod, director of the Center for Nursing Research at Penn State’s College of Nursing commented, “It’s a perfect case of integrating engineering with clinical nursing to produce medical devices that meet patient needs. The College of Nursing was involved from initial concept through development and testing, then creating instructional materials.”

Comments Off on Partnership with PSU Nursing School

Finalist for Patient Impact Award

Actuated Medical and its TubeClear system were chosen as one of three finalists for the Pennsylvania Bio Patient Impact Award. This award recognizes a medicine, therapy, device or organization that has made a significant contribution to the quality of health care or length of life of patients. The winner will be announced at Pennsylvania Bio’s Annual Dinner and Awards Celebration on March 12 in Philadelphia.

Comments Off on Finalist for Patient Impact Award

FDA Clearance for NE, G and J Usage

The FDA has cleared TubeClear specific to NE, G and J tubes. For institutions using the system for G and J tubes, TubeClear can provide substantial costs savings. Using typical replacement costs, our ROI Calculator shows $243,000 annual savings for a 500-bed facility.

Comments Off on FDA Clearance for NE, G and J Usage

Exhibiting at AACN

TubeClear will be on display at AACN’s National Teaching Institute (NTI) & Critical Care Exposition, May 21-23, 2013, Boston, MA. Actuated Medical will be exhibiting in Booth 1975 with hands-on demos and a team of experts.

Comments Off on Exhibiting at AACN

Join Us at Clinical Nutrition Week

Join us  February 9-12, 2013 in Phoenix at Clinical Nutrition Week hosted by ASPEN. Visit us at Booth 317 to see TubeClear in action. This is a great opportunity to try out the system and ask questions to our experts.

Comments Off on Join Us at Clinical Nutrition Week

FDA Clearance for NG Usage

The FDA has cleared TubeClear specific to Nasogastric (NG) feeding and decompression tubes. This allows sale of Control Box Model 101 and Clearing Stem Models NG-1036 and NG-1043 throughout the United States.

Comments Off on FDA Clearance for NG Usage

Kimal to Distribute TubeClear

Kimal plc has signed a distribution agreement with Actuated Medical to distribute TubeClear outside of the United States. Located in Uxbridge, United Kingdom, Kimal markets and distributes medical devices across the world.

Comments Off on Kimal to Distribute TubeClear

Market Awareness Demos

TubeClear market awareness product demonstrations will be available at Booth #1618 at the National Teaching Institute & Critical Care Exposition. The conference and expo will be held in Orlando, FL on May 22-24, 2012.

Comments Off on Market Awareness Demos